Developing enhanced immunotherapy using NKG2A knockout human pluripotent stem cell-derived NK cells.
Qin Y, Cui Q, Sun G, Chao J, Wang C, Chen X, Ye P, Zhou T, Jeyachandran AV, Sun O, Liu W, Yao S, Palmer C, Liu X, Arumugaswami V, Chan WC, Wang X, Shi Y.
Qin Y, et al. Among authors: palmer c.
Cell Rep. 2024 Nov 26;43(11):114867. doi: 10.1016/j.celrep.2024.114867. Epub 2024 Oct 23.
Cell Rep. 2024.
PMID: 39447568
Free article.